Equasens: 2023 Annual Results - 29.03.2024

29.03.2024 - Villers-lès-Nancy, 29 March 2024 - 6:00 p.m. (CET) PRESS RELEASE 2023 Annual Results Annual results impacted by the overperformance at the end of 2022 and early 2023 driven by solutions introduced under the Ségur programme as well as an ...

Related Keywords

Belgium ,Italy ,France ,Luxembourg ,Rotalier ,Franche Comtér ,Ireland ,Germany ,United Kingdom ,German ,Great Britain ,French ,Isabelle Aprile ,Equasens Groupwww ,Eligible For The Deferred Settlement Service ,Linkedin ,Julie Solutions ,Business Development ,Henry Schein Group ,Aboutequasens Group ,Compugroup Medical Solutions ,International Cross Talk ,Equasens Group ,Head Of The Medical Solutions Division ,Current Operating Margin ,Current Operating Profit ,Current Operating Income ,Net Profit Attributable ,Equity Holders ,Basic Earnings ,Annual General Meeting ,Chief Executive Officer ,Deputy Chief Executive ,Chief Business Development Officer ,Chief Executive ,French Pharmacy Business ,Medical Solutions ,Deputy Chief Executive Officer ,Euronext Paris ,Euronext Tech Leaders ,European Rising Tech ,Deferred Settlement Service ,Ticker Code ,Investor Relations ,Financial Officer ,Equasens Chart ,Quasens Kurs ,Quasens Aktie ,